We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
EOM Pharmaceutical Holdings Inc (PK) | USOTC:IMUC | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.199 | 0.06 | 0.20 | 0.199 | 0.1723 | 0.1723 | 1,100 | 21:01:51 |
Delaware
|
93-1301885
|
|
(State or other jurisdiction of
|
(IRS Employer
|
|
incorporation)
|
Identification No.)
|
This information, including exhibits attached hereto and the information under item 9.01 below, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
ImmunoCellular Therapeutics, Ltd.
|
||||||||
Date: May 08, 2014
|
By:
|
/s/ Andrew Gengos
|
||||||
Andrew Gengos
|
||||||||
President and Chief Executive Officer
|
||||||||
Exhibit No.
|
Description
|
|
EX-99.1
|
PRESS RELEASE, DATED MAY 8, 2014
|
|
EX-99.2
|
CONDENSED FINANCIAL STATEMENTS
|
1 Year EOM Pharmaceutical (PK) Chart |
1 Month EOM Pharmaceutical (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions